GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Return on Assets (ROA) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| ROA(%) | 25.15 | 17.87 | 15.76 | 10.11 | 9.52 |
What is the latest Return on Assets (ROA) ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Return on Assets (ROA) |
|---|---|
| Mar2025 | 25.15 |
| Mar2024 | 17.87 |
| Mar2023 | 15.76 |
| Mar2022 | 10.11 |
| Mar2021 | 9.52 |
How is Return on Assets (ROA) of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Return on Assets (ROA) | % Change | |
|---|---|---|---|
| Mar2025 | 25.15 | 40.74 | |
| Mar2024 | 17.87 | 13.39 | |
| Mar2023 | 15.76 | 55.89 | |
| Mar2022 | 10.11 | 6.20 | |
| Mar2021 | 9.52 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Assets (ROA) ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹44,905.4 Cr | 3.1% | 8.9% | 4.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 3.1% |
8.9% |
4.4% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses